Early Termination of Clinical Trials

"Early Termination of Clinical Trials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Earlier than planned termination of clinical trials.

Descriptor ID	D057239
MeSH Number(s)	E05.581.500.400 N04.761.559.590.800.379 N05.715.360.575.575.800.379
Concept/Terms	Early Termination of Clinical Trials Early Termination of Clinical Trials

Below are MeSH descriptors whose meaning is more general than "Early Termination of Clinical Trials".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Methods [E05.581]
Research Design [E05.581.500]
Early Termination of Clinical Trials [E05.581.500.400]
Health Care [N]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment (Health Care) [N04.761.559]
Outcome Assessment (Health Care) [N04.761.559.590]
Treatment Outcome [N04.761.559.590.800]
Early Termination of Clinical Trials [N04.761.559.590.800.379]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Outcome and Process Assessment (Health Care) [N05.715.360.575]
Outcome Assessment (Health Care) [N05.715.360.575.575]
Treatment Outcome [N05.715.360.575.575.800]
Early Termination of Clinical Trials [N05.715.360.575.575.800.379]

Below are MeSH descriptors whose meaning is related to "Early Termination of Clinical Trials".

Below are MeSH descriptors whose meaning is more specific than "Early Termination of Clinical Trials".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Early Termination of Clinical Trials" by people in this website by year, and whether "Early Termination of Clinical Trials" was a major or minor topic of these publications.

Bar chart showing 11 publications over 8 distinct years, with a maximum of 2 publications in 2010 and 2013 and 2016

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2010	2	2
2011	1	1
2012	1	1
2013	2	2
2014	1	1
2016	2	2
2019	1	1
2021	1	1

Below are the most recent publications written about "Early Termination of Clinical Trials" by people in Profiles.

Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, Eyzaguirre LM, Fowler AA, Gaieski DF, Gong MN, Hall A, Hinson JS, Hooper MH, Kelen GD, Khan A, Levine MA, Lewis RJ, Lindsell CJ, Marlin JS, McGlothlin A, Moore BL, Nugent KL, Nwosu S, Polito CC, Rice TW, Ricketts EP, Rudolph CC, Sanfilippo F, Viele K, Martin GS, Wright DW. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial. JAMA. 2021 02 23; 325(8):742-750.

View in: PubMed
Camm AJ, Dorian P, Hohnloser SH, Kowey PR, Tyl B, Ni Y, Vandzhura V, Maison-Blanche P, de Melis M, Sanders P. A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2019 01 01; 5(1):21-28.

View in: PubMed
Robinson VM, Bharucha DB, Mahaffey KW, Dorian P, Kowey PR. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial. Am Heart J. 2017 Mar; 185:43-51.

View in: PubMed
Mahida JB, Lodwick DL, Nacion KM, Sulkowski JP, Leonhart KL, Cooper JN, Ambeba EJ, Deans KJ, Minneci PC. High failure rate of nonoperative management of acute appendicitis with an appendicolith in children. J Pediatr Surg. 2016 Jun; 51(6):908-11.

View in: PubMed
McRee AJ, Davies JM, Sanoff HG, Goldberg RM, Bernard S, Dees EC, Keller K, Ivanova A, O'Neil BH. A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors. Cancer Chemother Pharmacol. 2014 Jul; 74(1):117-23.

View in: PubMed
Tarhini AA, Zahoor H, McLaughlin B, Gooding WE, Schmitz JC, Siegfried JM, Socinski MA, Argiris A. Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer. Anticancer Res. 2013 Oct; 33(10):4475-81.

View in: PubMed
Mess? SR, McGarvey ML, Bavaria JE, Pochettino A, Szeto WY, Cheung AT, Leitner E, Miller SW, Kasner SE. A pilot study of darbepoetin alfa for prophylactic neuroprotection in aortic surgery. Neurocrit Care. 2013 Feb; 18(1):75-80.

View in: PubMed
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2012; 7:CD003426.

View in: PubMed
Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer. 2012 May 1; 118(9):2378-84.

View in: PubMed
Goldberg RM, Bertagnolli MM. VICTOR spoiled? J Clin Oncol. 2010 Oct 20; 28(30):4546-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement